We will be attending the XIX International Symposium on Amyloidosis, taking place in Rochester, Minesota. Organised in collaboration with the ISA Board and members of Mayo Clinic, the program promises to be both informative and engaging.

The symposium will feature a comprehensive scientific program covering various types of systemic amyloidosis, including ATTR (hereditary and wild-type), AL (light-chain), AA, and less frequent forms.

The program will delve into the basic science, pathophysiology, diagnosis, and current and emerging treatments of systemic amyloidosis. Participants will have the opportunity to learn from competitive oral and poster abstracts, gaining insights into the latest advancements in the field.

We encourage you to join Dr. Taubel and other experts in the field for what promises to be an enlightening and educational experience. 

To find out more: https://cveducation.mayo.edu/store/international-symposium-on-amyloidosis 

Latest news

The Future of Cardiometabolic Research: Five Questions Shaping the Next Decade

October 22, 2026
Cardiometabolic research is continually evolving beyond explanations centred on single causes of disease.
Read more

Upcoming Event

AASLD

05 - 09 November 2026
Richmond Pharmacology is excited to join the AASLD Emerging Topic Conference: Unified Frontiers in Liver Disease in Denver, USA, on 05– 09 November 2026.
View event